Bacteriophage coliprophyte, 100 ml
€27.34 €22.79
The drug causes specific lysis of the bacteria Proteus vulgaris, Proteus mirabilis, Escherichia coli.
Indications
Treatment and prevention of purulent-inflammatory and enteric diseases, dysbiosis caused by Proteus bacteria and enteropathogenic Escherichia coli as part of complex therapy:
Diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy).
Surgical infections (wound suppuration, burns, abscess, phlegmon, boils, carbuncles, hidradenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis).
Urogenital infections (urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingoophoritis).
Enteral infections (gastroenterocolitis, cholecystitis), intestinal dysbiosis.
Generalized septic diseases.
Purulent-inflammatory diseases of newborns (omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.).
Other diseases caused by Proteus and Escherichia coli.
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Pharmacological effect
The drug causes specific lysis of bacteria Proteus vulgaris, Proteus mirabilis, Escherichia coli.
Special instructions
If there is turbidity, do not use the drug!
Due to the content of a nutrient medium in the drug, in which bacteria from the environment can develop, causing cloudiness of the drug, the following rules must be observed when opening the bottle:
Wash your hands thoroughly.
Treat the cap with an alcohol-containing solution.
Remove the cap without opening the cap.
Do not place the cork with the inner surface on a table or other objects.
Do not leave the bottle open.
Store an opened bottle only in the refrigerator.
When using small doses (2-8 drops), the drug must be taken with a sterile syringe in a volume of 0.5-1 ml.
The drug from an opened bottle, subject to storage conditions, the above rules and the absence of turbidity, can be used throughout the shelf life.
Impact on the ability to drive vehicles and operate machinery
Absent.
Active ingredient
Bacteriophage coliproteus
Composition
The solution contains:
Active substance:
mixture of sterile phagolysates of bacteria Proteus vulgaris, Proteus mirabilis and enteropathogenic Escherichia coli of various serogroups 100 ml.
Excipients:
8-hydroxyquinoline sulfate monohydrate 0.0001 g/ml.
Pregnancy
The use of this medication during pregnancy and breastfeeding is possible in the presence of infections caused by phage-sensitive strains of bacteria (as recommended by a doctor).
Contraindications
Hypersensitivity to the components of the drug.
Side Effects
Not installed.
Interaction
The drug can be used in combination with other drugs, including antibiotics.
Storage conditions
The drug is stored in accordance with SP 3.3.2.1248-03 in a dry place, protected from light and out of reach of children, at a temperature of 2 to 8 ° C.
Shelf life
2 years.
Manufacturer
Microgen NPO, Russia
Shelf life | 2 years. |
---|---|
Conditions of storage | The drug is stored in accordance with SP 3.3.2.1248-03 in a dry place protected from light and out of reach of children at 2 to 8 ° C. |
Manufacturer | Microgen NPO, Russia |
Medication form | oral solution and topical solution |
Brand | Microgen NPO |
Related products
Buy Bacteriophage coliprophyte, 100 ml with delivery to USA, UK, Europe and over 120 other countries.